v3.25.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Revenues      
Total revenues $ 4,848.9 $ 4,637.2 $ 4,812.6
Operating costs and expenses      
Operating expense, excluding depreciation and amortization below 1,786.0 1,679.4 1,691.5
Rent 887.3 873.6 873.5
General and administrative:      
Merger, acquisition and other costs 3.6 0.1 1.7
Other, excluding depreciation and amortization below 230.3 226.8 241.9
Depreciation and amortization 313.4 319.5 365.0
Impairment of long-lived assets 43.5 72.3 106.9
Operating costs and expenses 4,866.3 4,716.5 4,886.9
Operating loss (17.4) (79.3) (74.3)
Other expense, net:      
Other expense (income) 112.4 (156.2) (76.8)
Interest expense:      
Corporate borrowings 459.5 401.8 369.6
Finance lease obligations 6.0 5.4 3.7
Non-cash NCM exhibitor services agreement 64.7 36.5 37.9
Investment income (32.1) (16.3) (15.5)
Total other expense, net 610.5 271.2 318.9
Loss before income taxes (627.9) (350.5) (393.2)
Income tax provision 4.5 2.1 3.4
Net loss $ (632.4) $ (352.6) $ (396.6)
Net loss per share:      
Basic (in dollars per share) $ (1.34) $ (1.06) $ (2.37)
Diluted (in dollars per share) $ (1.34) $ (1.06) $ (2.37)
Weighted average shares outstanding:      
Basic (Shares in thousands) 472,899 332,920 167,644
Diluted (Shares in thousands) 472,899 332,920 167,644
Admissions      
Revenues      
Total revenues $ 2,652.8 $ 2,560.5 $ 2,690.5
Operating costs and expenses      
Operating costs and expenses 1,275.2 1,239.2 1,291.1
Food and beverage      
Revenues      
Total revenues 1,671.3 1,624.9 1,669.8
Operating costs and expenses      
Operating costs and expenses 327.0 305.6 315.3
Other theatre      
Revenues      
Total revenues $ 524.8 $ 451.8 $ 452.3

Source

10-K PDF
XBRL